Clinical Studies

Automated insulin delivery (AID) has increasingly become the standard of care for people with type 1 diabetes, driven by strong evidence of improved glycemic results.

Let’s face it, while diabetes technologies are often offered to patients with type 1 diabetes, the same options are not always given to patients with type 2 diabetes. But the paradigm is slowly shifting.